NASDAQ$OPCH

Option Care Health, Inc · Q4 2024 earnings

Q4 2024 earnings · · Before market open · Investor relations

Briefing

Option Care Health reported strong revenue and income growth in Q4 2024.

Option Care Health delivered solid financial results in Q4 2024 with net revenue growth of 19.7%, increased net income, and a higher adjusted EBITDA, demonstrating resilience in a dynamic market environment.

  • Net revenue increased by 19.7% to $1.35 billion.
  • Net income rose to $60.1 million, up from $57.2 million in Q4 2023.
  • Adjusted EBITDA grew by 8.9% to $121.6 million.
  • Adjusted diluted EPS increased by 15.8% to $0.44.

Headline financials

Total Revenue

$1.35B

Previous: $1.12B+19.8%
EPS (adj)

$0.44

Previous: $0.32+37.5%
Capital Expenditures

-$10.3M

Previous: -$19.9M+48.0%
Free Cash Flow

$36.1M

No prior period
Net Income

$60.1M

Previous: $57.2M+5.1%
Operating Income

$87M

Previous: $84.6M+2.9%
Gross Profit

$268M

Previous: $247M+8.6%

Revenue & EPS history

Option Care Health · Revenue · Quarterly

$1.35B

Q4 2024+19.8%vs Q4 2023
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Forward guidance

Option Care Health expects revenue growth, strong adjusted EBITDA, and continued operational resilience in FY 2025.

Tailwinds

  • Expected net revenue of $5.3 billion to $5.5 billion.
  • Adjusted EBITDA projected between $450 million and $470 million.
  • Adjusted diluted EPS anticipated between $1.59 and $1.69.
  • Cash flow from operations forecasted at $320 million or more.
  • Anticipated effective tax rate of 25%-27%.

Headwinds

  • Ongoing inflationary pressures.
  • Potential interest expense increase.
  • Market uncertainties.
  • Impact of non-operating income.
  • Competitive pressures in the healthcare industry.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

-1.9%

Avg return

Earnings day

-4.2%

Avg return

5 days after

-1.9%

Avg return

30 days after

50%

36 / 72 earnings

Positive

+27.4%

Q3 2015

Best reaction

-53.6%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-24.3%-20.7%-22.4%
Q4 2025-7.3%-10.1%-23.1%
Q3 2025-8.7%-5.7%+8.5%
Q1 2025-6.9%-0.1%-2.2%
Q4 2024+1.6%+4.1%+6.4%
Q3 2024-24.5%-26.3%-22.0%
Q2 2024-1.9%-5.3%+2.1%
Q1 2024-1.6%-2.6%-6.0%
Q4 2023-3.4%-1.8%-2.0%
Q3 2023-15.6%-18.4%-8.1%
Q2 2023+5.3%+4.0%+7.9%
Q1 2023-14.7%-12.6%-11.4%
Q4 2022+7.1%+6.3%+9.4%
Q3 2022-10.9%-13.3%-17.6%
Q2 2022+5.0%+4.8%-2.2%
Q1 2022+10.3%+7.4%+14.2%
Q4 2021+8.6%+10.8%+20.9%
Q3 2021-0.0%-2.1%-12.1%
Q2 2021-0.1%+8.3%+35.1%
Q1 2021-4.7%-8.8%+2.3%
Q4 2020+2.2%+1.9%-3.7%
Q3 2020+11.4%+11.7%+14.1%
Q2 2020+3.6%+1.7%-2.8%
Q1 2020+8.8%+6.6%+32.7%
Q4 2019-12.8%-16.1%-48.4%
Q3 2019-2.4%-5.9%-16.3%
Q2 2019-1.4%-5.2%+21.5%
Q1 2019-2.5%-1.5%-4.0%
Q4 2018-33.0%-38.7%-50.4%
Q3 2018+16.0%+12.8%+34.2%
Q2 2018-1.5%+2.5%+4.4%
Q1 2018-6.1%-0.4%+6.9%
Q4 2017+3.3%+0.0%+9.8%
Q3 2017-13.8%-18.8%+5.8%
Q2 2017+8.6%+21.8%+6.8%
Q1 2017+3.6%+1.8%+24.2%
Q4 2016-12.3%-10.6%-33.9%
Q3 2016-53.6%-47.9%-56.3%
Q2 2016+3.0%+2.6%+2.3%
Q1 2016+3.1%
Q4 2015+7.1%
Q3 2015+27.4%
Q2 2015-22.8%
Q1 2015-10.0%
Q4 2014-11.3%
Q3 2014+1.3%
Q2 2014-4.4%
Q1 2014+2.1%
Q4 2013+6.3%
Q2 1997+9.0%
Q3 2013-4.6%
Q2 2013-17.2%
Q1 2013-0.1%
Q4 2012-1.5%
Q3 2012+3.7%
Q2 2012+11.0%
Q1 2012+3.2%
Q4 2011-1.5%
Q3 2011-11.2%
Q2 2011+1.5%
Q4 2010+1.5%
Q1 2011-1.4%
Q3 2010+8.1%
Q2 2010-3.0%
Q1 2009+0.9%
Q1 2010+3.4%
Q2 2009+2.6%
Q4 2007+2.6%
Q4 2009+2.6%
Q3 2009+5.6%
Q3 2008+5.6%
Q4 2008+5.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro